biologics Flashcards

1
Q

what are biomacromolecular drugs

A

large (MW>2kD) biological molecules with therapeutic affect that are not accessible by chemical synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the key differences between small molecule drugs and biologics

A

biologics cannot be chemically synthesisedbiologics are not membrane permeable biologics are more sensitive to storage/handling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

give an example of a biomacromolecule

A

insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how is insulin produced

A

recombinant DNA technology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the steps in recombinant DNA technology

A
  1. gene identification, amplification, isolation 2. gene integration to vector 3. vector into host cell 4. cell growth5. cells containing target identified 6. isolation/purification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the options for hosting the biologics during amplification

A

e coli yeast animal cells insect cells plant cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the advantages to using e coli as a host cell

A

well characterised biology high expression of heterologous proteins quick and cheapcan be scaled up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the disadvantages to using e coli as a host cell

A

heterologous proteins accumulate intracellularlyno PTMpresence of pyrogenic LPS formation if inclusion bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does Heterologous mean

A

protein of interest does not occur naturally in the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are inclusion bodies

A

insoluble aggregates of partially soluble heterologous proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are PTM

A

Any covalent modification of peptide sequence once it has been formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which cell types can perform PTM

A

Prokaryotes do not have the necessary glycosylation machinery, so using eukaryotes to produce the protein (Chinese hamster ovary cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are two examples of PTM

A

glycosylation, phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the two types of glycosylation

A

n-linked o-linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what happens in n-linked glycosylation

A

Transfer of 14-mer oligosaccharide donor to protein as it emerges from rough ER - catalysed by oligosaccharyl transferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens in o-linked glycosylation

A

involves serine/threonine residues

17
Q

how does glycosylation work

A

requires sugar donor and an acceptor

18
Q

what is a glycoform

A

Variations in glycosylation patterns, have different stability, solubility, half life, biological activity and immunogenicity

19
Q

how are monoclonal antibodies manufactured

A

hybridoma technology

20
Q

how does hybridoma technology work

A

○ Mouse immunised and produce plasma cells/ antigens ○ Plasma cells mixed with immortal myeloma and fused with PEG ○ Cells grown in HAT medium - only allows fused cells to grow ○ Fused cells showing high desired protein are expanded and grown in large numbers

21
Q

how is the desired protein recovered from host cells

A

1 from cell 2 chromatography

22
Q

how is the desired protein recovered from host cells - cellular

A

1) Chemical treatment 2) Sonication/homogenisation 3) Agitation in presence of abrasives

23
Q

how is the desired protein recovered from host cells - chromatography

A

1) Affinity chromatography 2) Ion exchange chromatography 3) Gel filtration chromatography

24
Q

what are biosimilars

A

biologics cannot be copied due to complexity of processing, Any biologic that results from this repeat process is called a biosimilar